Home Companies Illumina

Illumina

Latest

Liquid Biopsies

StockWatch: Icahn Pursues Illumina Board Seats, and a Sell-Off of Grail

Next-Generation Sequencing

StockWatch: Analysts Mixed on Illumina after Q4 Results, Delivery of First NovaSeq X Plus System

Financing

EY Eyes Comeback for Biopharma M&A

Whole-Genome Analysis

At JPM, Illumina Announces African-American Sequencing Collaboration

Alzheimers

StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure

Illumina

Illumina Reveals New High-Throughput Instrument, NovaSeq X

Barack Obama DNA Illumina Genomics Forum

Illumina

At Illumina Genomics Forum, Obama Prescribes Diversity, Resilience to Drive Precision...

Illumina

Illumina Predictions: What Will They Reveal at This Week’s Forum?

Illumina

StockWatch: Illumina Bounces Back After FTC Win, EU Loss

Illumina

Judge Sides with Illumina, Rejecting FTC Challenge to Grail Deal

Next-Generation Sequencing

X Marks the $100 Genome: Illumina Presents New Chemistry, Strong Results

Next-Generation Sequencing

Fast and Flexible: Singular’s G4 Takes Aim at Illumina’s Sequencing Superiority

Sequencing

Introducing “Close to the Edge”: A Zoom Conversation with PacBio CEO...

Illumina

Illumina Vows to Fight Back as FTC Takes Aim at $8B...

Beautiful Korean woman with cancer smiles at doctor

Illumina

Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform

12 3 Page 1 of 3